JANX vs SRPT · rev $10.3M vs rev $1.13B
Janux Therapeutics Inc (JANX) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Janux Therapeutics Inc (JANX) is a biotechnology company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported JANX revenue for 2026-06-30 was $10.3M. Net income was -$22.0M. JANX currently screens at market cap $1.49B.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
JANX currently screens at market cap $1.49B. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the JANX and SRPT stock pages for the full models.
Not investment advice.